Stockscreener 앱 받기
0.50%
Amgen Inc 주식(AMGN)의 최신 뉴스
Mirae Asset Global Investments Co. Ltd. Has $186.70 Million Stake in Amgen Inc. $AMGN - MarketBeat
Assessing Whether Amgen (AMGN) Still Looks Undervalued After Recent Share Price Pullback - simplywall.st
Argo Wealth Advisory LLC Purchases New Shares in Amgen Inc. $AMGN - MarketBeat
AE Wealth Management LLC Has $43.90 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Federal Circuit Distinguishes Amgen in Reversal of Invalidation of Teva Headache Treatment Patents - IPWatchdog.com
Amgen Inc. stock (US0311621009): Is obesity drug momentum strong enough to unlock new upside? - AD HOC NEWS
Idiopathic Pulmonary Fibrosis Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | GSK, Amgen, Boehringer Ingelheim, PureTech, Guangzhou JOYO Pharma, Tvardi Therapeutics, Pliant - Barchart.com
Amgen Shares Acquired by Lbp Am Sa - National Today
Migraine Market: Pharma Pipeline Fuels Rapid Expansion by 2034 – DelveInsight | Eli Lilly and Company, Axsome Therapeutics, AEON Biopharma, Charleston Laboratories, Amgen, Teva Pharma, Anne Lindblad - Barchart.com
KBC Group NV Has $187.27 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Lbp Am Sa - MarketBeat
Amgen Extends Cuala GAA Title Sponsorship Through 2029 - Sport for Business
Amgen Inc. $AMGN Shares Purchased by Farther Finance Advisors LLC - MarketBeat
Amgen Inc. $AMGN Shares Bought by Cwm LLC - MarketBeat
Amgen Inc. stock (US0311621009): Is its biotech innovation edge strong enough for steady gains? - AD HOC NEWS
2 Reasons to Like AMGN and 1 to Stay Skeptical - Yahoo Finance
Amgen Inc. stock (US0311621009): Is its biotech innovation edge strong enough to unlock new upside? - AD HOC NEWS
Amgen Inc. stock (US0311621009): Is its obesity drug pipeline strong enough to unlock new upside? - AD HOC NEWS
Amgen And Zai Lab Trial Tests DLL3 Combo As Valuation Looks Undemanding - Yahoo Finance
Amgen Inc. stock (US0311621009): Is obesity drug momentum strong enough to sustain long-term growth? - AD HOC NEWS
Amgen Inc. stock (US0311621009): Is obesity drug momentum strong enough to drive new upside? - AD HOC NEWS
Amgen And Zai Lab DLL3 Alliance Adds New Dimension To Oncology Story - simplywall.st
Assetmark Inc. Increases Stake in Amgen Inc. - National Today
Assetmark Inc. Buys 14,341 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. (AMGN): Billionaire Ken Fisher doubles bullish position - MSN
AMGN Maintained by UBS -- Price Target Raised to $400 - GuruFocus
Amgen (NASDAQ:AMGN) Price Target Raised to $400.00 - MarketBeat
Morgan Stanley Raises Amgen (AMGN) Target Ahead of Q1, Truist Lifts Outlook on Pipeline Strength - Insider Monkey
Eosinophilic Esophagitis Market in the US to Grow at 13.2% CAGR During the Forecast Period (2026–2036) Owing to the Emergence of Drug Classes Such as TSLP Inhibitors, Glucocorticoid Receptor Agonists, and Immunomodulators | DelveInsight - GlobeNewswire Inc.
‘Community Day Presented by Amgen’ Mobilizes Volunteers to Touch Up Greater Los Angeles Ahead of FIFA World Cup 2026 - Amgen
Beat the Market the Zacks Way: FirstEnergy, Seanergy Maritime, Amgen in Focus - Yahoo Finance
HBW Advisory Services LLC Has $2.07 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen Settles Denosumab Biosimilar Lawsuits with Henlius and Organon - National Today
Amgen and BeOne Medicines get Chinese approval for small cell lung cancer drug - Mugglehead Investment Magazine
Sumitomo Mitsui Trust Group Reduces Stake in Amgen - National Today
Kelsey Financial LLC Makes New $7.13 Million Investment in Amgen Inc. $AMGN - MarketBeat
Sumitomo Mitsui Trust Group Inc. Has $527.74 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
Robeco Institutional Asset Management B.V. Increases Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by KG&L Capital Management LLC - MarketBeat
Curtis Advisory Group Adds Amgen Shares to Portfolio - National Today
Curtis Advisory Group LLC Makes New Investment in Amgen Inc. $AMGN - MarketBeat
Factory Mutual Insurance Trims Amgen Stake - National Today
Assessing Amgen (AMGN) Valuation As TEPEZZA And MariTide Trial Results Draw Fresh Investor Focus - Yahoo Finance
Clarity Wealth Advisors LLC Invests $3.91 Million in Amgen Inc. $AMGN - MarketBeat
Amgen (NASDAQ:AMGN) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Is It Time To Revisit Amgen (AMGN) After The Recent 4.6% Share Price Pullback - simplywall.st
AVALON CAPITAL MANAGEMENT's Amgen Inc(AMGN) Holding History - GuruFocus
Amgen Inc. stock underperforms Friday when compared to competitors - MarketWatch
China Approves Amgen's Tarlatamab for Previously Treated Extensive-Stage Small Cell Lung Cancer | PharmExec - Pharmaceutical Executive
Why Amgen (AMGN) is poised to beat earnings estimates again - MSN
Amgen’s FORWARD II Gout Study: What a Less Frequent Krystexxa Schedule Could Mean for Investors - TipRanks
Amgen-Backed DLL3 Combo Trial Could Be A Game Changer For Zai Lab (ZLAB) - simplywall.st
Why Amgen (AMGN) is Poised to Beat Earnings Estimates Again - Yahoo Finance
OFI Invest Asset Management Boosts Amgen Stock Position - National Today
Amgen’s lung cancer drug tarlatamab wins China approval - WTAQ
Amgen (NASDAQ:AMGN) Price Target Raised to $326.00 - MarketBeat
Amgen’s Tarlatamab Approved in China - Pharmaceutical Executive
NK Cell Therapy Pipeline 2026: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Amgen, ImmunityBio, Dragonfly Therapeutics, Glycostem Therapeutics, Athenex, Artiva Biotherap - Barchart
Intratumoral Cancer Therapies Market: Expanding Revenue Landscape to 2034 – DelveInsight | Amgen, Daiichi Sankyo, AiViva BioPharma, Lytix Biopharma, Regeneron Pharma, Checkmate Pharma, Replimune - Barchart
OFI Invest Asset Management Increases Stake in Amgen - National Today
OFI Invest Asset Management Increases Stock Position in Amgen Inc. $AMGN - MarketBeat
Prime Capital Investment Advisors LLC Has $6.32 Million Stake in Amgen Inc. $AMGN - MarketBeat
Encompass Wealth Advisors Trims Amgen Stake by Over 50% - National Today
Amgen's lung cancer drug tarlatamab wins China approval - Reuters
Encompass Wealth Advisors LLC Sells 3,010 Shares of Amgen Inc. $AMGN - MarketBeat
0.59%
자본화:
|
볼륨(24시간):